Global Intravenous Fluid Bags 麻豆原创 Growth 2025-2031

Publication ID:

LPI03253054

Publication Date:

March 21, 2025

Pages:

135

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Intravenous Fluid Bags market size is predicted to grow from US$ 1770 million in 2025 to US$ 2573 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.
Intravenous Fluid Bags are sterile containers used to hold intravenous fluids that are administered directly into a patient's bloodstream. These bags contain solutions such as saline, glucose, or electrolytes, which help maintain hydration, deliver medications, or provide nutrients to patients who cannot consume them orally. Intravenous Fluid Bags are commonly used in hospitals, clinics, and emergency settings to treat dehydration, replenish blood volume, and support patients during surgeries or illness.
The growing prevalence of chronic diseases such as diabetes, cancer, and kidney disorders is a significant driver of the Intravenous Fluid Bags market. As patients with these conditions often require regular fluid administration and medication delivery through IV therapy, the demand for Intravenous Fluid Bags is increasing globally. Additionally, the rising number of surgical procedures, the aging population, and the increasing adoption of home healthcare services are further boosting the demand for these bags in both hospital and outpatient settings.
A key challenge in the Intravenous Fluid Bags market is the fluctuating cost and availability of raw materials, particularly for non-PVC bags, which are increasingly in demand due to concerns over the harmful effects of PVC and DEHP. This drives up production costs and may limit access in regions with lower healthcare budgets. Moreover, stringent regulatory standards for the manufacturing and approval of Intravenous Fluid Bags add complexity to market entry, requiring companies to invest heavily in compliance and quality assurance.
Europe is the largest consumption place, with a consumption market share nearly 34% in 2023. Following Europe, North America is the second largest consumption place with the consumption market share of 20%. Baxter, SSY Group, B.Braun, Fresenius Kabi, Otsuka, Cisen Pharmaceutical, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The 鈥淚ntravenous Fluid Bags Industry Forecast鈥� looks at past sales and reviews total world Intravenous Fluid Bags sales in 2024, providing a comprehensive analysis by region and market sector of projected Intravenous Fluid Bags sales for 2025 through 2031. With Intravenous Fluid Bags sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Fluid Bags industry.
This Insight Report provides a comprehensive analysis of the global Intravenous Fluid Bags landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Fluid Bags portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Intravenous Fluid Bags market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Fluid Bags and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Fluid Bags.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Fluid Bags market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Flex Plastic IV Bags
厂别尘颈-谤颈驳颈诲听滨痴听叠补驳蝉
骋濒补蝉蝉听叠辞迟迟濒别蝉
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Baxter
SSY Group
B.Braun
Fresenius Kabi
Pfizer
Otsuka
Cisen Pharmaceutical
Renolit
Technoflex
Huaren Pharmaceutical
CR Double-Crane
ICU Medical
Pharmaceutical Solutions Industry Ltd
Vioser
Sippex
Well Pharma
Zhejiang CHIMIN
Key Questions Addressed in this Report
What is the 10-year outlook for the global Intravenous Fluid Bags market?
What factors are driving Intravenous Fluid Bags market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravenous Fluid Bags market opportunities vary by end market size?
How does Intravenous Fluid Bags break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Intravenous Fluid Bags Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Intravenous Fluid Bags by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Intravenous Fluid Bags by Country/Region, 2020, 2024 & 2031
2.2 Intravenous Fluid Bags Segment by Type
2.2.1 Flex Plastic IV Bags
2.2.2 厂别尘颈-谤颈驳颈诲听滨痴听叠补驳蝉
2.2.3 骋濒补蝉蝉听叠辞迟迟濒别蝉
2.3 Intravenous Fluid Bags Sales by Type
2.3.1 Global Intravenous Fluid Bags Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Intravenous Fluid Bags Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Intravenous Fluid Bags Sale Price by Type (2020-2025)
2.4 Intravenous Fluid Bags Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Intravenous Fluid Bags Sales by Application
2.5.1 Global Intravenous Fluid Bags Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Intravenous Fluid Bags Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Intravenous Fluid Bags Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Intravenous Fluid Bags Breakdown Data by Company
3.1.1 Global Intravenous Fluid Bags Annual Sales by Company (2020-2025)
3.1.2 Global Intravenous Fluid Bags Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Intravenous Fluid Bags Annual Revenue by Company (2020-2025)
3.2.1 Global Intravenous Fluid Bags Revenue by Company (2020-2025)
3.2.2 Global Intravenous Fluid Bags Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Intravenous Fluid Bags Sale Price by Company
3.4 Key Manufacturers Intravenous Fluid Bags Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous Fluid Bags Product Location Distribution
3.4.2 Players Intravenous Fluid Bags Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Intravenous Fluid Bags by Geographic Region
4.1 World Historic Intravenous Fluid Bags 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Intravenous Fluid Bags Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Intravenous Fluid Bags Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Intravenous Fluid Bags 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Intravenous Fluid Bags Annual Sales by Country/Region (2020-2025)
4.2.2 Global Intravenous Fluid Bags Annual Revenue by Country/Region (2020-2025)
4.3 Americas Intravenous Fluid Bags Sales Growth
4.4 APAC Intravenous Fluid Bags Sales Growth
4.5 Europe Intravenous Fluid Bags Sales Growth
4.6 Middle East & Africa Intravenous Fluid Bags Sales Growth
5 Americas
5.1 Americas Intravenous Fluid Bags Sales by Country
5.1.1 Americas Intravenous Fluid Bags Sales by Country (2020-2025)
5.1.2 Americas Intravenous Fluid Bags Revenue by Country (2020-2025)
5.2 Americas Intravenous Fluid Bags Sales by Type (2020-2025)
5.3 Americas Intravenous Fluid Bags Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous Fluid Bags Sales by Region
6.1.1 APAC Intravenous Fluid Bags Sales by Region (2020-2025)
6.1.2 APAC Intravenous Fluid Bags Revenue by Region (2020-2025)
6.2 APAC Intravenous Fluid Bags Sales by Type (2020-2025)
6.3 APAC Intravenous Fluid Bags Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Intravenous Fluid Bags by Country
7.1.1 Europe Intravenous Fluid Bags Sales by Country (2020-2025)
7.1.2 Europe Intravenous Fluid Bags Revenue by Country (2020-2025)
7.2 Europe Intravenous Fluid Bags Sales by Type (2020-2025)
7.3 Europe Intravenous Fluid Bags Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intravenous Fluid Bags by Country
8.1.1 Middle East & Africa Intravenous Fluid Bags Sales by Country (2020-2025)
8.1.2 Middle East & Africa Intravenous Fluid Bags Revenue by Country (2020-2025)
8.2 Middle East & Africa Intravenous Fluid Bags Sales by Type (2020-2025)
8.3 Middle East & Africa Intravenous Fluid Bags Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Fluid Bags
10.3 Manufacturing Process Analysis of Intravenous Fluid Bags
10.4 Industry Chain Structure of Intravenous Fluid Bags
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous Fluid Bags Distributors
11.3 Intravenous Fluid Bags Customer
12 World Forecast Review for Intravenous Fluid Bags by Geographic Region
12.1 Global Intravenous Fluid Bags 麻豆原创 Size Forecast by Region
12.1.1 Global Intravenous Fluid Bags Forecast by Region (2026-2031)
12.1.2 Global Intravenous Fluid Bags Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Intravenous Fluid Bags Forecast by Type (2026-2031)
12.7 Global Intravenous Fluid Bags Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Intravenous Fluid Bags Product Portfolios and Specifications
13.1.3 Baxter Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 SSY Group
13.2.1 SSY Group Company Information
13.2.2 SSY Group Intravenous Fluid Bags Product Portfolios and Specifications
13.2.3 SSY Group Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 SSY Group Main Business Overview
13.2.5 SSY Group Latest Developments
13.3 B.Braun
13.3.1 B.Braun Company Information
13.3.2 B.Braun Intravenous Fluid Bags Product Portfolios and Specifications
13.3.3 B.Braun Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 B.Braun Main Business Overview
13.3.5 B.Braun Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Intravenous Fluid Bags Product Portfolios and Specifications
13.4.3 Fresenius Kabi Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Intravenous Fluid Bags Product Portfolios and Specifications
13.5.3 Pfizer Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Otsuka
13.6.1 Otsuka Company Information
13.6.2 Otsuka Intravenous Fluid Bags Product Portfolios and Specifications
13.6.3 Otsuka Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Otsuka Main Business Overview
13.6.5 Otsuka Latest Developments
13.7 Cisen Pharmaceutical
13.7.1 Cisen Pharmaceutical Company Information
13.7.2 Cisen Pharmaceutical Intravenous Fluid Bags Product Portfolios and Specifications
13.7.3 Cisen Pharmaceutical Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Cisen Pharmaceutical Main Business Overview
13.7.5 Cisen Pharmaceutical Latest Developments
13.8 Renolit
13.8.1 Renolit Company Information
13.8.2 Renolit Intravenous Fluid Bags Product Portfolios and Specifications
13.8.3 Renolit Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Renolit Main Business Overview
13.8.5 Renolit Latest Developments
13.9 Technoflex
13.9.1 Technoflex Company Information
13.9.2 Technoflex Intravenous Fluid Bags Product Portfolios and Specifications
13.9.3 Technoflex Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Technoflex Main Business Overview
13.9.5 Technoflex Latest Developments
13.10 Huaren Pharmaceutical
13.10.1 Huaren Pharmaceutical Company Information
13.10.2 Huaren Pharmaceutical Intravenous Fluid Bags Product Portfolios and Specifications
13.10.3 Huaren Pharmaceutical Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Huaren Pharmaceutical Main Business Overview
13.10.5 Huaren Pharmaceutical Latest Developments
13.11 CR Double-Crane
13.11.1 CR Double-Crane Company Information
13.11.2 CR Double-Crane Intravenous Fluid Bags Product Portfolios and Specifications
13.11.3 CR Double-Crane Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 CR Double-Crane Main Business Overview
13.11.5 CR Double-Crane Latest Developments
13.12 ICU Medical
13.12.1 ICU Medical Company Information
13.12.2 ICU Medical Intravenous Fluid Bags Product Portfolios and Specifications
13.12.3 ICU Medical Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 ICU Medical Main Business Overview
13.12.5 ICU Medical Latest Developments
13.13 Pharmaceutical Solutions Industry Ltd
13.13.1 Pharmaceutical Solutions Industry Ltd Company Information
13.13.2 Pharmaceutical Solutions Industry Ltd Intravenous Fluid Bags Product Portfolios and Specifications
13.13.3 Pharmaceutical Solutions Industry Ltd Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Pharmaceutical Solutions Industry Ltd Main Business Overview
13.13.5 Pharmaceutical Solutions Industry Ltd Latest Developments
13.14 Vioser
13.14.1 Vioser Company Information
13.14.2 Vioser Intravenous Fluid Bags Product Portfolios and Specifications
13.14.3 Vioser Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Vioser Main Business Overview
13.14.5 Vioser Latest Developments
13.15 Sippex
13.15.1 Sippex Company Information
13.15.2 Sippex Intravenous Fluid Bags Product Portfolios and Specifications
13.15.3 Sippex Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Sippex Main Business Overview
13.15.5 Sippex Latest Developments
13.16 Well Pharma
13.16.1 Well Pharma Company Information
13.16.2 Well Pharma Intravenous Fluid Bags Product Portfolios and Specifications
13.16.3 Well Pharma Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Well Pharma Main Business Overview
13.16.5 Well Pharma Latest Developments
13.17 Zhejiang CHIMIN
13.17.1 Zhejiang CHIMIN Company Information
13.17.2 Zhejiang CHIMIN Intravenous Fluid Bags Product Portfolios and Specifications
13.17.3 Zhejiang CHIMIN Intravenous Fluid Bags Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Zhejiang CHIMIN Main Business Overview
13.17.5 Zhejiang CHIMIN Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.